“Bimekizumab Remission and High Disease Control Over 4 Years in Patients With Psoriasis Achieving Complete Skin Clearance at Week 16: Results from Four Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s758. Accessed April 29, 2026. https://skin.dermsquared.com/skin/article/view/4085.